HIV/AIDS Vertical Transmission
HIV rescreening during late pregnancy to prevent vertical transmission is cost-effective
Published in AIDS Weekly, August 14th, 2006
According to recent research from the United States, "A decision analysis model, from a health care system perspective, was used to assess the cost-effectiveness of HIV rescreening during late pregnancy to prevent perinatal HIV transmission in South Africa, a country with high HIV prevalence and incidence among pregnant women.
"Because new HIV prenatal prophylactic and pediatric antiretroviral therapy (ART) regimens are becoming more widely available, the study was carried out with different combinations of the two."
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2006-08-14)
More Articles from AIDS Weekly
- HIV/AIDS Behavioral Medicine
Nine to 10% of men worldwide exchanged sex for money within 12-month period - HIV/AIDS Diagnostics
HIV detected in saliva by immunological and molecular testing methods - HIV/AIDS Elite Suppressors
HIV suppression maintained in HLA-B*57+ elite suppressors despite CTL escape mutations - HIV/AIDS Vertical Transmission
Short-course nucleoside analogues safe and effective for prevention of vertical HIV transmission - Antibacterial Agents
Bacterial skin pathogen invasion inhibited by quinine sulfate - Business Update
CytRx President and CEO Steven Kriegsman talks to The Wall Street Transcript - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
